| Primary |
| Product Used For Unknown Indication |
37.2% |
| Headache |
9.3% |
| Pain |
7.9% |
| Back Pain |
5.9% |
| Drug Use For Unknown Indication |
5.2% |
| Arthritis |
5.1% |
| Arthralgia |
4.3% |
| Analgesic Therapy |
3.6% |
| Dysmenorrhoea |
3.4% |
| Toothache |
2.5% |
| Rheumatoid Arthritis |
2.4% |
| Hypertension |
2.3% |
| Osteoarthritis |
1.7% |
| Juvenile Arthritis |
1.7% |
| Pain In Extremity |
1.6% |
| Diabetes Mellitus |
1.3% |
| Muscle Spasms |
1.2% |
| Musculoskeletal Pain |
1.2% |
| Neck Pain |
1.2% |
| Blood Cholesterol Increased |
0.9% |
|
| No Adverse Event |
38.0% |
| Headache |
11.4% |
| Drug Ineffective |
8.5% |
| Pain |
6.8% |
| Hypersensitivity |
3.3% |
| Feeling Abnormal |
3.1% |
| Somnolence |
2.8% |
| Toxicity To Various Agents |
2.8% |
| Urticaria |
2.7% |
| Back Pain |
2.4% |
| Drug Hypersensitivity |
2.3% |
| Arthralgia |
2.1% |
| Dysmenorrhoea |
2.1% |
| Euphoric Mood |
2.0% |
| Malaise |
1.9% |
| Abdominal Pain Upper |
1.6% |
| Death |
1.6% |
| Muscle Spasms |
1.6% |
| Renal Failure Acute |
1.6% |
| Vomiting |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
15.8% |
| Drug Use For Unknown Indication |
13.7% |
| Pain |
7.9% |
| Rheumatoid Arthritis |
7.3% |
| Arthritis |
6.0% |
| Osteoarthritis |
4.5% |
| Diabetes Mellitus |
4.3% |
| Hypertension |
4.3% |
| Systemic Lupus Erythematosus |
4.2% |
| Arthralgia |
3.8% |
| Musculoskeletal Pain |
3.5% |
| Osteoporosis |
3.5% |
| Fibromyalgia |
3.3% |
| Myalgia |
3.2% |
| Hypermobility Syndrome |
3.1% |
| Back Pain |
3.0% |
| Blood Cholesterol Increased |
2.4% |
| Headache |
2.3% |
| Suicide Attempt |
2.2% |
| Musculoskeletal Chest Pain |
1.7% |
|
| Drug Hypersensitivity |
27.7% |
| Renal Failure Acute |
7.8% |
| Dyspepsia |
6.6% |
| Toxicity To Various Agents |
4.8% |
| Angioedema |
4.2% |
| Drug Ineffective |
4.2% |
| Gastrointestinal Haemorrhage |
4.2% |
| Incorrect Dose Administered |
4.2% |
| Bowel Movement Irregularity |
3.6% |
| Suicidal Ideation |
3.6% |
| Vomiting |
3.6% |
| Death |
3.0% |
| Gastric Ulcer |
3.0% |
| Hallucination |
3.0% |
| Heart Rate Decreased |
3.0% |
| No Adverse Event |
3.0% |
| Rash |
3.0% |
| Completed Suicide |
2.4% |
| Malaise |
2.4% |
| Melaena |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.4% |
| Rheumatoid Arthritis |
14.7% |
| Product Used For Unknown Indication |
11.5% |
| Pain |
11.1% |
| Hypertension |
4.6% |
| Depression |
3.4% |
| Asthma |
2.4% |
| Vitamin Supplementation |
2.1% |
| Psoriatic Arthropathy |
2.1% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Multiple Sclerosis |
1.9% |
| Arthritis |
1.8% |
| Contraception |
1.8% |
| Juvenile Arthritis |
1.8% |
| Premenstrual Syndrome |
1.7% |
| Acne |
1.6% |
| Migraine |
1.6% |
| Diabetes Mellitus |
1.5% |
| Hypothyroidism |
1.4% |
| Multiple Myeloma |
1.4% |
|
| Vomiting |
13.1% |
| Nausea |
8.6% |
| Weight Increased |
7.8% |
| Weight Decreased |
7.4% |
| Injury |
6.1% |
| Pulmonary Embolism |
6.1% |
| Pain |
5.7% |
| Drug Ineffective |
4.5% |
| Flushing |
4.1% |
| Pain In Extremity |
4.1% |
| Rheumatoid Arthritis |
3.7% |
| Urticaria |
3.7% |
| Abdominal Pain Upper |
3.3% |
| Pruritus |
3.3% |
| Sinusitis |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Vision Blurred |
3.3% |
| Accidental Exposure |
2.9% |
| Surgery |
2.9% |
| Urinary Tract Infection |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
50.7% |
| Arthralgia |
6.8% |
| Thrombosis Prophylaxis |
6.8% |
| Hip Arthroplasty |
4.1% |
| Knee Arthroplasty |
4.1% |
| Procedural Pain |
4.1% |
| Rheumatoid Arthritis |
4.1% |
| Anxiety |
2.7% |
| Musculoskeletal Chest Pain |
2.7% |
| Urinary Tract Infection |
2.7% |
| Bursitis |
1.4% |
| Cough |
1.4% |
| Hypertension |
1.4% |
| Intervertebral Disc Protrusion |
1.4% |
| Nerve Injury |
1.4% |
| Neuropathy Peripheral |
1.4% |
| Pain Management |
1.4% |
| Wheezing |
1.4% |
|
| Drug Interaction |
21.4% |
| Asthenia |
7.1% |
| Gastrointestinal Haemorrhage |
7.1% |
| Headache |
7.1% |
| Hyperkalaemia |
7.1% |
| Increased Tendency To Bruise |
7.1% |
| Melaena |
7.1% |
| Oedema |
7.1% |
| Respiratory Tract Haemorrhage |
7.1% |
| Syncope |
7.1% |
| Upper Gastrointestinal Haemorrhage |
7.1% |
| Urogenital Haemorrhage |
7.1% |
|
